Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Young Women's Health CoOp (Cooperative) in Cape Town (YWHC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02677025
Recruitment Status : Completed
First Posted : February 9, 2016
Last Update Posted : June 9, 2016
Sponsor:
Collaborator:
Medical Research Council, South Africa
Information provided by (Responsible Party):
RTI International

Brief Summary:
This supplement study is an adaptation of the larger NIH-funded parent study, the Women's Health CoOp+, which tests a combination biobehavioral HIV prevention approach to enhance standard HIV testing practices for alcohol and drug (AOD)-using women across the city of Pretoria, South Africa. The current supplemental study seeks to reach AOD-using female adolescents who experience the greatest burden of new HIV infections and are currently underserved by HIV and drug-treatment programs in Cape Town, South Africa and test the validation of both the instrument and adapted intervention.

Condition or disease Intervention/treatment Phase
HIV Substance Abuse Behavioral: Young Women's Health CoOp (YWHC) Behavioral: HIV Counseling/Testing Not Applicable

Detailed Description:

This study is testing and validating both the revised instrument and adapted intervention through a small pilot trial where a cluster randomized design is used to recruit 100 participants through snowball sampling by community to either the YWHC condition or standard HIV Counseling and Testing (HCT); collect biological specimens to screen for recent drug use, pregnancy and HIV infection and provide referrals for care to resources; conduct process evaluation measures for satisfaction and a 1-month follow-up post-intervention interview assessing the feasibility and preliminary efficacy of conducting this intervention among vulnerable young women and linking them to care.

Young women from disadvantaged communities in Cape Town who have dropped out of school and who use AODs are highly vulnerable to physical victimization (violence and sexual victimization) from any perpetrator, including main sexual partners and drug-related sexual risks for HIV. Yet these vulnerable young women remain underserved by current HIV and drug treatment programs in the region, even though they are experiencing the greatest burden of new HIV infections in the country. The adapted Young Women's Health CoOp (YWHC) intervention has a high likelihood of wider implementation, sustainability, and a significant public health impact by reducing the exceedingly high HIV incidence amongst the most vulnerable populations in South Africa.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Seek, Test, Treat, & Retain Pilot for Out of School Teens at Risk in Cape Town
Study Start Date : May 2014
Actual Primary Completion Date : April 2016
Actual Study Completion Date : April 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Young Women's Health CoOp (YWHC)
This is an adapted behavioral intervention for young women in Cape Town South Africa who dropped out of school, who use alcohol and other drugs and are at risk for HIV.
Behavioral: Young Women's Health CoOp (YWHC)
Participants in this group will participate in two workshops of the young woman-focused intervention about HIV/STIs (sexually transmitted infections), sexual behaviors, alcohol and other drug use, violence, communication skills, and other issues. Participants will develop personalized risk reduction action plans at the end of each workshop session.

Active Comparator: HIV Counseling/Testing
Provide age and gender appropriate standard HIV counseling and testing.
Behavioral: HIV Counseling/Testing
Participants will be tested for HIV and if positive will receive counseling in accordance with national standards.




Primary Outcome Measures :
  1. Unprotected intercourse among women [ Time Frame: One month post-intervention ]
    Percentages of condom use at last sex


Secondary Outcome Measures :
  1. Alcohol use [ Time Frame: One month post-intervention ]
    Frequency of alcohol use in past 30 days measured by RRBA (Revised Risk Behavior Assessment) and breath test

  2. Alcohol use [ Time Frame: One month post-intervention ]
    Frequency of alcohol use in past 30 days measured by breath test

  3. Substance use [ Time Frame: One month post-intervention ]
    Use of benzodiazepines, cocaine, methamphetamine, MDMA (methylenedioxymethamphetamine), marijuana and/or mandrax as determined by PRBA (Pretoria Risk Behavior Assessment)

  4. Substance use [ Time Frame: One month post-intervention ]
    Use of benzodiazepines, cocaine, methamphetamine, MDMA (methylenedioxymethamphetamine), marijuana and/or mandrax as determined by self-report

  5. Victimization [ Time Frame: One month post-intervention ]
    Percentages of young women who report being beaten in the previous 30 days

  6. Victimization [ Time Frame: One month post-intervention ]
    Percentages of young women who report being attacked with a weapon in the previous 30 days

  7. Victimization [ Time Frame: One month post-intervention ]
    Percentages of young women who report being forced to have sex in the previous 30 days



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years to 21 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Female, 16 to 21 years of age
  • Dropped out of school for at least 6 months
  • Currently dropped out of school
  • Have not completed matric or N 3 certificate
  • Have used at least one drug (which can include alcohol) at least weekly in the past 90 days
  • Report unprotected sex with a male partner in the last 90 days
  • Able to provide informed assent to participate or informed consent if at least 18 years old
  • Live in a targeted community Delft, Khayelitsha, or Mfuleni

Exclusion Criteria:

• Have been a part of formative activities


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02677025


Locations
Layout table for location information
United States, North Carolina
RTI International
Research Triangle Park, North Carolina, United States, 27709
Sponsors and Collaborators
RTI International
Medical Research Council, South Africa
Investigators
Layout table for investigator information
Principal Investigator: Wendee M Wechsberg, PhD Director of RTI Global Gender Center, Senior Director of SATEI
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: RTI International
ClinicalTrials.gov Identifier: NCT02677025    
Other Study ID Numbers: R01DA032061 ( U.S. NIH Grant/Contract )
First Posted: February 9, 2016    Key Record Dates
Last Update Posted: June 9, 2016
Last Verified: June 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: After the main findings are published, we welcome other researchers who want to analyze the data in other ways. Before this time, however, we anticipate establishing a publication plan that involves other researchers and institutions. Analytic data sets will be prepared in accordance with the "Privacy Rule" of the Health Insurance Portability and Accountability Act (HIPAA; http://www.hhs.gov/ocr/) as "limited data sets" in which names and other personal health identifiers are removed, birthdays have been converted to age at intake, and other dates have been changed to be days before or after the date of intake.
Keywords provided by RTI International:
HIV
Sexual Risk
Sexually Transmitted Diseases
Substance Abuse
Violence and Victimization
Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders